Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Preparation and functional studies of hydroxyethyl chitosan nanoparticles loaded with anti-human death receptor 5 single-chain antibody.

Yang J, Huang X, Luo F, Cheng X, Cheng L, Liu B, Chen L, Hu R, Shi C, Zhuang G, Yin P.

Onco Targets Ther. 2014 May 21;7:779-87. doi: 10.2147/OTT.S59872. eCollection 2014.

2.

Preparation of carboplatin-Fe@C-loaded chitosan nanoparticles and study on hyperthermia combined with pharmacotherapy for liver cancer.

Li FR, Yan WH, Guo YH, Qi H, Zhou HX.

Int J Hyperthermia. 2009 Aug;25(5):383-91. doi: 10.1080/02656730902834949.

PMID:
19391033
3.

Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects.

Cheng MR, Li Q, Wan T, He B, Han J, Chen HX, Yang FX, Wang W, Xu HZ, Ye T, Zha BB.

World J Gastroenterol. 2012 Nov 14;18(42):6076-87. doi: 10.3748/wjg.v18.i42.6076.

4.

Cytotoxicity and apoptotic effects of tea polyphenol-loaded chitosan nanoparticles on human hepatoma HepG2 cells.

Liang J, Li F, Fang Y, Yang W, An X, Zhao L, Xin Z, Cao L, Hu Q.

Mater Sci Eng C Mater Biol Appl. 2014 Mar 1;36:7-13. doi: 10.1016/j.msec.2013.11.039. Epub 2013 Dec 5.

PMID:
24433880
5.

Downregulation of VEGF mRNA expression by triamcinolone acetonide acetate-loaded chitosan derivative nanoparticles in human retinal pigment epithelial cells.

Zhou H, Yang L, Li H, Gong H, Cheng L, Zheng H, Zhang LM, Lan Y.

Int J Nanomedicine. 2012;7:4649-60. doi: 10.2147/IJN.S29690. Epub 2012 Aug 22.

6.

Anti-tumor immune response of folate-conjugated chitosan nanoparticles containing the IP-10 gene in mice with hepatocellular carcinoma.

Lai C, Yu X, Zhuo H, Zhou N, Xie Y, He J, Peng Y, Xie X, Luo G, Zhou S, Zhao Y, Lu X.

J Biomed Nanotechnol. 2014 Dec;10(12):3576-89.

PMID:
26000371
7.

Chitosan nanoparticle as protein delivery carrier--systematic examination of fabrication conditions for efficient loading and release.

Gan Q, Wang T.

Colloids Surf B Biointerfaces. 2007 Sep 1;59(1):24-34. Epub 2007 Apr 24.

PMID:
17555948
8.

Influence of charge on FITC-BSA-loaded chondroitin sulfate-chitosan nanoparticles upon cell uptake in human Caco-2 cell monolayers.

Hu CS, Chiang CH, Hong PD, Yeh MK.

Int J Nanomedicine. 2012;7:4861-72. doi: 10.2147/IJN.S34770. Epub 2012 Aug 10.

9.

Preparation of chitosan-plasmid DNA nanoparticles encoding interleukin-12 and their expression in CT-26 colon carcinoma cells.

Hallaj-Nezhadi S, Valizadeh H, Dastmalchi S, Baradaran B, Jalali MB, Dobakhti F, Lotfipour F.

J Pharm Pharm Sci. 2011;14(2):181-95.

10.

Docetaxel loaded chitosan nanoparticles: formulation, characterization and cytotoxicity studies.

Jain A, Thakur K, Kush P, Jain UK.

Int J Biol Macromol. 2014 Aug;69:546-53. doi: 10.1016/j.ijbiomac.2014.06.029. Epub 2014 Jun 24.

PMID:
24971551
11.

Novel stable cytokine delivery system in physiological pH solution: chitosan oligosaccharide/heparin nanoparticles.

Wang B, Tan L, Deng D, Lu T, Zhou C, Li Z, Tang Z, Wu Z, Tang H.

Int J Nanomedicine. 2015 May 8;10:3417-27. doi: 10.2147/IJN.S82091. eCollection 2015.

12.

In vitro and in vivo suppression of hepatocellular carcinoma growth by chitosan nanoparticles.

Qi L, Xu Z, Chen M.

Eur J Cancer. 2007 Jan;43(1):184-93. Epub 2006 Oct 17.

PMID:
17049839
13.

Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.

Chen H, Xie LQ, Qin J, Jia Y, Cai X, Nan W, Yang W, Lv F, Zhang QQ.

Colloids Surf B Biointerfaces. 2016 Feb 1;138:1-9. doi: 10.1016/j.colsurfb.2015.11.033. Epub 2015 Nov 28.

PMID:
26638176
14.

Preparation and characterization of PE38KDEL-loaded anti-HER2 nanoparticles for targeted cancer therapy.

Chen H, Gao J, Lu Y, Kou G, Zhang H, Fan L, Sun Z, Guo Y, Zhong Y.

J Control Release. 2008 Jun 24;128(3):209-16. doi: 10.1016/j.jconrel.2008.03.010. Epub 2008 Mar 19.

PMID:
18450313
15.

Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles.

Duan J, Zhang Y, Han S, Chen Y, Li B, Liao M, Chen W, Deng X, Zhao J, Huang B.

Int J Pharm. 2010 Nov 15;400(1-2):211-20. doi: 10.1016/j.ijpharm.2010.08.033. Epub 2010 Sep 8.

PMID:
20813175
16.

A sustained release formulation of chitosan modified PLCL:poloxamer blend nanoparticles loaded with optical agent for animal imaging.

Ranjan AP, Zeglam K, Mukerjee A, Thamake S, Vishwanatha JK.

Nanotechnology. 2011 Jul 22;22(29):295104. doi: 10.1088/0957-4484/22/29/295104. Epub 2011 Jun 21.

PMID:
21693801
17.

5-flourouracil loaded N,O-carboxymethyl chitosan nanoparticles as an anticancer nanomedicine for breast cancer.

Anitha A, Chennazhi KP, Nair SV, Jayakumar R.

J Biomed Nanotechnol. 2012 Feb;8(1):29-42.

PMID:
22515092
18.

Nanofabrication of methylglyoxal with chitosan biopolymer: a potential tool for enhancement of its anticancer effect.

Pal A, Talukdar D, Roy A, Ray S, Mallick A, Mandal C, Ray M.

Int J Nanomedicine. 2015 May 12;10:3499-518. doi: 10.2147/IJN.S78284. eCollection 2015.

19.

Gene therapy based on interleukin-12 loaded chitosan nanoparticles in a mouse model of fibrosarcoma.

Soofiyani SR, Hallaj-Nezhadi S, Lotfipour F, Hosseini AM, Baradaran B.

Iran J Basic Med Sci. 2016 Nov;19(11):1238-1244.

20.

Supplemental Content

Support Center